<p dir="ltr">This research proposal outlines an open-label, single-arm pilot trial designed to explore the potential role of a synergistic nutraceutical regimen in promoting fallopian tube recovery in women with tubal-factor infertility. The formulation—Quercetin, Bromelain, Zinc, Vitamin C, and Vitamin D3—is selected based on its anti-inflammatory, immune-modulating, and fibrinolytic properties. The protocol evaluates safety, biomarker shifts (IL-6, TNF-α, CRP, D-dimer), and signs of tubal function and spontaneous conception in a 12-week supplementation period.</p><p dir="ltr">The study builds on prior mucosal repair mechanisms demonstrated in an IBD protocol (Orzechowski, 2025).</p><p><br></p><p dir="ltr">DOI: https://doi.org/10.6084/m9.figshare.29832914</p><p dir="ltr">Protocol ID: QzBCD-001</p><p dir="ltr">Version: 1.0</p><p dir="ltr">Date: August 2025</p><p dir="ltr">Status: Pre-IRB Research Proposal</p><p dir="ltr">Sponsor/PI: To Be Determined</p>